Unknown

Dataset Information

0

Gold nanoparticle-M2e conjugate coformulated with CpG induces protective immunity against influenza A virus.


ABSTRACT: This study aimed to develop a novel influenza A vaccine by conjugating the highly conserved extracellular region of the matrix 2 protein (M2e) of influenza A virus to gold nanoparticles (AuNPs) and to test the vaccine in a mouse influenza challenge model.Citrate-reduced AuNPs (diameter: 12 nm) were synthesized, and characterized by transmission electron microscopy and dynamic light scattering. M2e was conjugated to AuNPs through thiol-gold interactions to form M2e-AuNP conjugates. Particle stability was confirmed by UV-visible spectra, and M2e conjugation was further characterized by x-ray photoelectron spectroscopy. Mice were immunized with M2e-AuNPs with or without CpG (cytosine-guanine rich oligonucleotide) as an adjuvant with appropriate control groups. Sera was collected and M2e-specific immunoglobulin (IgG) was measured, and immunized mice were challenged with PR8-H1N1 influenza virus.M2e-capped AuNPs could be lyophilized and stably resuspended in water. Intranasal vaccination of mice with M2e-AuNP conjugates induced M2e-specific IgG serum antibodies, which significantly increased upon addition of soluble CpG as adjuvant. Upon challenge with lethal PR8, mice vaccinated with M2e-AuNP conjugates were only partially protected, while mice that received soluble CpG as adjuvant in addition to M2e-AuNP were fully protected.Overall, this study demonstrates the potential of using the M2e-AuNP conjugates with CpG as an adjuvant as a platform for developing an influenza A vaccine.

SUBMITTER: Tao W 

PROVIDER: S-EPMC3958969 | biostudies-literature | 2014 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Gold nanoparticle-M2e conjugate coformulated with CpG induces protective immunity against influenza A virus.

Tao Wenqian W   Ziemer Katherine S KS   Gill Harvinder S HS  

Nanomedicine (London, England) 20130705 2


<h4>Aim</h4>This study aimed to develop a novel influenza A vaccine by conjugating the highly conserved extracellular region of the matrix 2 protein (M2e) of influenza A virus to gold nanoparticles (AuNPs) and to test the vaccine in a mouse influenza challenge model.<h4>Materials & methods</h4>Citrate-reduced AuNPs (diameter: 12 nm) were synthesized, and characterized by transmission electron microscopy and dynamic light scattering. M2e was conjugated to AuNPs through thiol-gold interactions to  ...[more]

Similar Datasets

| S-EPMC8832387 | biostudies-literature
| S-EPMC5555299 | biostudies-other
| S-EPMC6980908 | biostudies-literature
| S-EPMC4418433 | biostudies-literature
| S-EPMC7060564 | biostudies-literature
| S-EPMC4873889 | biostudies-other
| S-EPMC3948190 | biostudies-literature
| S-EPMC6146233 | biostudies-literature
| S-EPMC3462204 | biostudies-literature
| S-EPMC9978532 | biostudies-literature